RAPGEF6
Rap guanine nucleotide exchange factor 6
Also known as: PDZ-GEF2, PDZGEF2, RA-GEF-2, RPGF6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8TEU7
- Gene
- RAPGEF6
- Ensembl
- ENSG00000158987
- Chromosome
- 5
- Canonical length
- 1601 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Centrosome,Cytosol
OverviewNCBI Gene
Enables several functions, including GTP-dependent protein binding activity; guanyl-nucleotide exchange factor activity; and phosphatidic acid binding activity. Involved in microvillus assembly; positive regulation of GTPase activity; and protein localization to plasma membrane. Located in several cellular components, including apical plasma membrane; centrosome; and endocytic vesicle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
1601 residues, UniProt reviewed canonical sequence.
>Q8TEU7|RAPGEF6
1 MNSPVDPGAR QALRKKPPER TPEDLNTIYS YLHGMEILSN LREHQLRLMS ARARYERYSG
61 NQVLFCSETI ARCWYILLSG SVLVKGSMVL PPCSFGKQFG GKRGCDCLVL EPSEMIVVEN
121 AKDNEDSILQ REIPARQSRR RFRKINYKGE RQTITDDVEV NSYLSLPADL TKMHLTENPH
181 PQVTHVSSSQ SGCSIASDSG SSSLSDIYQA TESEVGDVDL TRLPEGPVDS EDDEEEDEEI
241 DRTDPLQGRD LVRECLEKEP ADKTDDDIEQ LLEFMHQLPA FANMTMSVRR ELCSVMIFEV
301 VEQAGAIILE DGQELDSWYV ILNGTVEISH PDGKVENLFM GNSFGITPTL DKQYMHGIVR
361 TKVDDCQFVC IAQQDYWRIL NHVEKNTHKV EEEGEIVMVH EHRELDRSGT RKGHIVIKAT
421 PERLIMHLIE EHSIVDPTYI EDFLLTYRTF LESPLDVGIK LLEWFKIDSL RDKVTRIVLL
481 WVNNHFNDFE GDPAMTRFLE EFEKNLEDTK MNGHLRLLNI ACAAKAKWRQ VVLQKASRES
541 PLQFSLNGGS EKGFGIFVEG VEPGSKAADS GLKRGDQIME VNGQNFENIT FMKAVEILRN
601 NTHLALTVKT NIFVFKELLF RTEQEKSGVP HIPKIAEKKS NRHSIQHVPG DIEQTSQEKG
661 SKKVKANTVS GGRNKIRKIL DKTRFSILPP KLFSDGGLSQ SQDDSIVGTR HCRHSLAIMP
721 IPGTLSSSSP DLLQPTTSML DFSNPSDIPD QVIRVFKVDQ QSCYIIISKD TTAKEVVFHA
781 VHEFGLTGAS DTYSLCEVSV TPEGVIKQRR LPDQFSKLAD RIQLNGRYYL KNNMETETLC
841 SDEDAQELVK ESQLSMLQLS TIEVATQLSM RDFDLFRNIE PTEYIDDLFK LNSKTGNTHL
901 KRFEDIVNQE TFWVASEILT EANQLKRMKI IKHFIKIALH CRECKNFNSM FAIISGLNLA
961 SVARLRGTWE KLPSKYEKHL QDLQDIFDPS RNMAKYRNIL SSQSMQPPII PLFPVVKKDM
1021 TFLHEGNDSK VDGLVNFEKL RMISKEIRQV VRMTSANMDP AMMFRQRSLS QGSTNSNMLD
1081 VQGGAHKKRA RRSSLLNAKK LYEDAQMARK VKQYLSSLDV ETDEEKFQMM SLQWEPAYGT
1141 LTKNLSEKRS AKSSEMSPVP MRSAGQTTKA HLHQPHRVSQ VLQVPAVNLH PIRKKGQTKD
1201 PALNTSLPQK VLGTTEEISG KKHTEDTISV ASSLHSSPPA SPQGSPHKGY TLIPSAKSDN
1261 LSDSSHSEIS SRSSIVSNCS VDSMSAALQD ERCSSQALAV PESTGALEKT EHASGIGDHS
1321 QHGPGWTLLK PSLIKCLAVS SSVSNEEISQ EHIIIEAADS GRGSWTSCSS SSHDNFQSLP
1381 NPKSWDFLNS YRHTHLDDPI AEVEPTDSEP YSCSKSCSRT CGQCKGSLER KSWTSSSSLS
1441 DTYEPNYGTV KQRVLESTPA ESSEGLDPKD ATDPVYKTVT SSTEKGLIVY CVTSPKKDDR
1501 YREPPPTPPG YLGISLADLK EGPHTHLKPP DYSVAVQRSK MMHNSLSRLP PASLSSNLVA
1561 CVPSKIVTQP QRHNLQPFHP KLGDVTDADS EADENEQVSA VLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RAPGEF6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 21 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 21 nTPM
- lymph node: 20 nTPM
- tonsil: 17 nTPM
- thymus: 14 nTPM
- testis: 12 nTPM
- appendix: 12 nTPM
Single-cell type
- microglia: 528 nCPM
- oligodendrocytes: 484 nCPM
- brain excitatory neurons: 297 nCPM
- brain inhibitory neurons: 271 nCPM
- other brain neurons: 215 nCPM
- oligodendrocyte progenitor cells: 198 nCPM
Immune cell
- naive CD4 T-cell: 15 nTPM
- T-reg: 12 nTPM
- MAIT T-cell: 12 nTPM
- naive CD8 T-cell: 11 nTPM
- neutrophil: 10 nTPM
- memory CD4 T-cell: 9.2 nTPM
Brain region
- cerebellum: 107 nTPM
- pons: 73 nTPM
- white matter: 67 nTPM
- medulla oblongata: 59 nTPM
- hypothalamus: 59 nTPM
- cerebral cortex: 58 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.56
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- microvillus assembly
- positive regulation of microvillus assembly
- protein localization to plasma membrane
- Ras protein signal transduction
- regulation of GTPase activity
Molecular functions
- GTP-dependent protein binding
- guanyl-nucleotide exchange factor activity
- phosphatidic acid binding
- small GTPase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ras-associating domain
- Cyclic nucleotide-binding domain
- Ras-like guanine nucleotide exchange factor, N-terminal
- PDZ domain
- Ras guanine-nucleotide exchange factors catalytic domain
- RmlC-like jelly roll fold
- Cyclic nucleotide-binding domain superfamily
- Ras guanine nucleotide exchange factor domain superfamily
- PDZ superfamily
- Ras guanine-nucleotide exchange factor, catalytic domain superfamily
- Cyclic nucleotide-binding domain
- PDZ domain
- RasGEF domain
- RasGEF N-terminal motif
- Ras association (RalGDS/AF-6) domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RAPGEF6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RAPGEF6 as an antibody target. Whether an autoantibody or antibody against RAPGEF6 could matter depends on whether native RAPGEF6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RAPGEF6 is annotated at the cell surface, where native RAPGEF6 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RAPGEF6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...